Stem Cell Therapy Market to Worth Over US$ 2,612.92 Million By 2033 | Astute Analytica [Yahoo! Finance]
Cell Source, Inc. (CLCS)
NASDAQ:AMEX Investor Relations:
ir.cell-source.com/news/detail/11/cell-source-inc-announces-the-launch-of-its-new-investor-relations-website
Company Research
Source: Yahoo! Finance
With groundbreaking advancements, regulatory progress, and increasing clinical success, it holds unparalleled potential to redefine healthcare, enhance lives, and drive the future of regenerative medicine globally. New Delhi, Dec. 09, 2024 (GLOBE NEWSWIRE) -- The global stem cell therapy market was valued at US$ 394.50 million in 2023 and is projected to reach US$ 2,612.92 million by 2033 at a CAGR of 23.97% during the forecast period 2025–2033. North America dominates the market, capturing 51.86% of revenue in 2023, while the Asia-Pacific region is expected to grow at a CAGR of 25.03% from 2024 to 2033. Allogeneic stem cell therapy held the largest market share, contributing 59% of revenue in 2023, while regenerative medicine accounted for 93% of total revenues. The U.S. stem cell therapy market alone is projected to hit $16.61 billion by 2032, driven by advancements like CRISPR gene editing and 3D bioprinting, which are attracting significant investments. Additionally, Californi
Show less
Read more
Impact Snapshot
Event Time:
CLCS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CLCS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CLCS alerts
High impacting Cell Source, Inc. news events
Weekly update
A roundup of the hottest topics
CLCS
News
- Cell Source Shares Promising Interim Results From Groundbreaking Veto Cell Clinical Trial [Yahoo! Finance]Yahoo! Finance
- Cell Source Shares Promising Interim Results From Groundbreaking Veto Cell Clinical TrialAccesswire
- Stem Cell Therapy Market Analysis Report 2024-2029: iPSC Technology and Personalized Medicine Trends Drive Growth [Yahoo! Finance]Yahoo! Finance